EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III

Mashroor Khan iD, Sofia Skröder iD, Michael Ingre, Fredrik Carlstedt, Anders Eriksson, Johanna Star Tenn, Mårten Rosenqvist iD, Emma Svennberg iD

Europace · 2026

DOI: 10.1093/europace/euag214 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2026. Verfasst von Mashroor Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm SE 141 86, Sweden. Hauptthemen laut MEDLINE: Atrial Fibrillation, Mass Screening, Patient Participation. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart and Lung foundation, CIMED, Vinnova, Swedish Research Council, Region Stockholm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Population-based screening for atrial fibrillation (AF) should be considered in elderly individuals to enable AF detection. However, participation in systematic screening programmes is often suboptimal. STROKESTOP III evaluated whether opportunistic screening could improve participation compared with systematic screening. Methods and results STROKESTOP III is a cluster-randomized trial including individuals aged 75–76 years from 16 primary care centres in Region Värmland, Sweden. Centres were randomized to systematic screening, using mailed invitations, or opportunistic screening, using invitations during visits. In the systematic arm, 1312 individuals were eligible and invited, of whom 607 participated (46.3%). In the opportunistic arm, 1390 individuals attended participating primary care centres and were potentially eligible for invitation. However, 641 individuals (46.1%) were not assessed for eligibility. Among the 749 assessed individuals, 609 were eligible and 374 participated. Participation among invited eligible individuals was significantly higher with opportunistic than systematic screening (374/609, 61.4% vs. 607/1,312, 46.3%; P < 0.005). However, overall reach was lower in the opportunistic arm because of incomplete assessment for invitation (374/1,479, 25.3% vs. 607/1,437, 42.2%; P < 0.005). Participants in the opportunistic arm had a higher cardiovascular risk burden, including more hypertension, diabetes, and a higher CHA2DS2-VASc-score (3.99 vs. 3.60; P < 0.005). Exclusion rates were higher (18.7% vs. 8.7%; P < 0.005), mainly due to previously diagnosed AF and cognitive impairment.

Conclusion

Opportunistic screening increased participation among invited individuals and identified a higher-risk population, but its overall population reach was limited by incomplete eligibility assessment. Combining opportunistic and systematic strategies may optimize reach and participation in AF screening programmes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationMass ScreeningPatient ParticipationHumansAgedSwedenFemaleMaleRisk FactorsPrimary Health CarePredictive Value of Tests

Stichwörter der Autor:innen

Atrial fibrillationOpportunistic screeningOral anticoagulantsScreeningStroke

Autor:innen und Institutionen

  • Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm SE 141 86, Sweden.
  • Centre for Clinical Research and Education, Region Värmland, Karlstad, Sweden.
  • Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
  • Department of Clinical Physiology, Region Värmland, Karlstad, Sweden.
  • Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Danderyd, Sweden.

ORCID-Profile: Mashroor Khan, Sofia Skröder, Mårten Rosenqvist, Emma Svennberg

Förderung

  • Swedish Heart and Lung foundation, CIMED, Vinnova
  • Swedish Research Council
  • Region Stockholm

Zitieren

APA

Khan, M., Skröder, S., Ingre, M., Carlstedt, F., Eriksson, A., Star Tenn, J., Rosenqvist, M., & Svennberg, E. (2026). Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III. Europace. https://doi.org/10.1093/europace/euag214

Vancouver

Khan M, Skröder S, Ingre M, Carlstedt F, Eriksson A, Star Tenn J, et al. Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III. Europace. 2026. doi:10.1093/europace/euag214

BibTeX
@article{Khan2026,
  author = {Khan, Mashroor and Skröder, Sofia and Ingre, Michael and Carlstedt, Fredrik and Eriksson, Anders and Star Tenn, Johanna and Rosenqvist, Mårten and Svennberg, Emma},
  title = {Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag214}
}
Kostenlos starten →